Introduction
Panama: Forging a Path Toward International Science Hub by Dr. Ruben Berrocal I am delighted to write an introduction to this supplemental issue of the Journal of Alzheimer's Disease (JAD).
As JAD continues to serve as one of the most prolific, highly cited, and recognized publications on Alzheimer's and neurodegenerative diseases, I am pleased to share with you some of our perspectives and developments in this important field of study and where Panama might offer solutions.
While we witness exciting breakthroughs in fighting neurodegenerative diseases like Alzheimer's and Parkinson's diseases, more must be done. Perhaps now more than ever, it is critical we continue apace to eradicate these diseases through new discoveries and novel methods.
Currently, innovations are being sought to find new pathways to a cure. Research on new drug discoveries has shifted focus to the natural world and the critical need to develop biomarkers that can distinguish the normal aging processes from neurodegeneration and other dementias. These findings should prove invaluable to early diagnosis of these diseases -the first line of defense.
In this area, Panama can offer new hope in groundbreaking research and drug developments. In what a recent article in Nature, one of the world's most cited scientific journals, referred to as Panama's "big ambition" in the moment of our "scientific renaissance," we are forging a new direction in drug discoveries, clinical trials and research incubators. 1 Under President Ricardo Martinelli's leadership, we are aiming high, seeking to become an international hub for science and technology; and be among the leaders in bioscience and biomedicine in our hemisphere. Our rich natural resources and dedicated scientists offer us a means for growth in this field that is second to none in the region.
Panama: Forging a Path Toward International Science Hub
Neurodegenerative diseases have a complex pathology and etiology and we do not know enough about them. For instance, we have yet to discover a cellular/animal model that accurately replicates their degenerative effects as seen in the human brain. As this field of study becomes more important given our ever-growing and aging populations, the time to find a cure is now.
Neuroscientists in Panama are working to develop cognitive, neurochemical, and imaging biomarkers to better understand degenerative diseases, as well as a comprehensive database on brain disorders. In addition, our drug discovery scientists are focusing on identifying novel molecules from marine biodiversity as neuroprotective agents.
Panama is undertaking major investments in the field of science, innovation, and technology. We have set aside more than $50 million this year, with a plan to increase that figure to 0.5% of GDP over the next few years. We are optimistic that given this pledge, and Panama's abundant flora and fauna, we will produce vital solutions to finding new disease-modifying agents among us.
Recently, our government signed a memorandum of understanding with a leading U.S. university hospital and research facility to establish a drug discovery center in Panama. And we will continue to seek out mutually beneficial alliances to attract the best and brightest to Panama, further demonstrating our serious commitment.
Investments like these, and cultivating important collaborations, will offer significant contributions that the scientific community must make to solve the dilemmas of the 21st century. For our part, it is important that we foster a culture of competitiveness in our global economy by creating world leaders in science, innovation, and technology. This is our moment, and we are ready to rise to the occasion.
Panama has a profound understanding of what can be accomplished when collective will and ingenuity confront considerable challenges. If not for the global commitment of the brave workers and brilliant engineers who built the Panama Canal, we may have not yet discovered a vaccine for yellow fever. Without unified commitments like these, we often deprive one another of our potential.
Curing neurodegenerative disease is no less daunting a task, but we must continue to seek out new solutions to better understand it, control it, and ultimately eliminate it.
And while we will long feel the loss of one of the field's great contributors in Dr. Mark A. Smith, we must continue to pioneer great work, such as his, that pushes the boundaries of contemporary science, medicine, and conventional wisdom. In this, we find ourselves in our hour of great potential, and on the shoulders of giants. 
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